LGND (Ligand) Kelajakdagi narxning foydaga nisbati

Ligand (LGND) kompaniyasining rasmiy ramzlari

Ligand Pharmaceuticals (LGND) global laboratoriyalar uchun qadrli hamkor bo'lib, eruvchanlik innovatsiyalari orqali muhim dori vositalarining bozorga chiqishini tezlashtirmoqda. GURU.Markets terminali kompaniyaning prognoz qilingan P/E koeffitsiyentini taqdim etadi, bunda metrika qiymati 25.30 ni tashkil etadi. Bu holat kompaniyaning benuqson imidjga ega sanoatning "yashirin dahosi" sifatidagi maqomini ta'kidlaydi, barqaror boshqaruv esa intellektual mulkni bashorat qilinadigan royalti to'lovlari orqali samarali monetizatsiya qilmoqda.

ligand.com - LGND Kapitalizatsiyaning kelajakdagi foydaga nisbati (davr: 04.07.2022 - 17.11.2026)

ligand.com (LGND) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Fundamental baholash:LGND Ligand Pharma
Ligand Pharmaceuticals brendining mahsuloti

Prognoz qilinayotgan P/E ko'rsatkichi joriy aksiya narxini kutilayotgan aksiya boshiga foyda bilan solishtirish orqali biznes qiymatiga oid bozor kutganlarini aks ettiradi. Ligand Pharmaceuticals (LGND) kompaniyasining baholanishini prognoz qilinayotgan P/E orqali tahlil qilish yordamida investor bozor onkologik dori vositalaridan kelajakda tushadigan royalti va litsenziya to'lovlarini qanday chegirayotganini ko'rishi mumkin, bu esa intellektual mulkni aniq moliyaviy koeffitsiyentga aylantiradi.

Raqobatdosh kompaniyalar

Kelajakdagi narxning foydaga nisbati haleon.com (HLN)|KVUE (Kenvue Health) - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Verona Pharma PLC VRNA|Jyong Biotech (MENS) - Prognoz qilingan narx-foyda nisbati|AMRX: Prognoz qilingan narxning foydaga nisbati|Perrigo - Kapitalizatsiyaning kelajakdagi foydaga nisbati|ALVO: Forvard P/E multiplikatori|Liquidia Technologies - Kelajakdagi narx-foyda multiplikatori|GLPG (Galapagos N.V.) - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati anipharmaceuticals.com ANIP|Kelajakdagi narxning foydaga nisbati MannKind (MNKD)|AMPH (Amphastar Pharmaceuticals, Inc.) - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Pacira BioSciences, Inc. PCRX|Forvard P/E multiplikatori ARS Corp SPRY|Theravance Biopharma - Forvard P/E multiplikatori|Forvard narx-foyda multiplikatori Aquestive Therapeutics, Inc. (AQST)|scPharmaceuticals (SCPH) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Tectonic Therapeutic, Inc.|TNXP (Tonix Pharmaceuticals Holding) - Forvard P/E multiplikatori|Narxning kelajakdagi foydaga nisbati SXTC (China SXT Pharmaceuticals)|Forvard P/E multiplikatori EPRX|Forvard P/E multiplikatori bioharvest.com (BHST)|Kelajakdagi narxning foydaga nisbati Invizyne Technologies EXOZ|ORMP: Narxning kelajakdagi foydaga nisbati|ENTX: Prognoz qilingan narxning foydaga nisbati|HYFT: Kelajakdagi narxning foydaga nisbati|ABVC BioPharma Inc. (ABVC) - Kelajakdagi narxning foydaga nisbati|cumberlandpharma.com (CPIX) - Forvard P/E multiplikatori|QNTM (Quantum BioPharma) - Forvard P/E multiplikatori|FGEN: Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori TELO|Forvard P/E multiplikatori Rani Therapeutics Holdings (RANI)|Forvard P/E multiplikatori SNYR (Synergy CHC Corp)|Rallybio Corporation (RLYB) - Prognoz qilingan narx-foyda nisbati|LEXX - Kelajakdagi narxning foydaga nisbati|PULM (Pulmatrix) - Narxning kelajakdagi foydaga nisbati|Pheton Holdings Ltd (PTHL) - Kelajakdagi narxning foydaga nisbati|Aptorum - Kelajakdagi narx-foyda multiplikatori|Prognoz qilingan narxning foydaga nisbati LYRA|Prognoz qilingan narxning foydaga nisbati Impact BioMedical Inc (IBO)|Forvard P/E multiplikatori TNFA|YCBD: Narxning kutilayotgan foydaga nisbati|Kelajakdagi narxning foydaga nisbati PainReform PRFX|altamiratherapeutics.com (CYTO) - Prognoz qilingan narx-foyda nisbati|LIPO: Prognoz qilingan narxning foydaga nisbati|OPTN (optinose.com) - Narxning kelajakdagi foydaga nisbati|PIRS: Forvard P/E multiplikatori|PROC - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|PTPI (Petros Pharma) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati QLI|Forvard P/E multiplikatori SLRN|Kapitalizatsiyaning kelajakdagi foydaga nisbati TFFP